An update on the management of urinary tract infections in the era of antimicrobial resistance
MS Bader, M Loeb, AA Brooks - Postgraduate medicine, 2017 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited therapeutic options. Gram-negative bacteria, specifically …
growing concern due to limited therapeutic options. Gram-negative bacteria, specifically …
Antibiotic resistant superbugs: assessment of the interrelationship of occurrence in clinical settings and environmental niches
The increasing threat to global health posed by antibiotic resistance remains of serious
concern. Human health remains at higher risk due to several reported therapeutic failures to …
concern. Human health remains at higher risk due to several reported therapeutic failures to …
Febrile urinary-tract infection due to extended-spectrum beta-lactamase–producing Enterobacteriaceae in children: A French prospective multicenter study
Objectives To assess the management of febrile urinary-tract infection (FUTIs) due to
extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-E) in children, the …
extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-E) in children, the …
Extended Spectrum Beta‐Lactamase (ESBL) Produced by Gram‐Negative Bacteria in Trinidad and Tobago
PE Akpaka, A Vaillant, C Wilson… - International Journal of …, 2021 - Wiley Online Library
Gram‐negative bacterial infections are a global health problem. The production of beta‐
lactamase is still the most vital factor leading to beta‐lactam resistance. In Trinidad and …
lactamase is still the most vital factor leading to beta‐lactam resistance. In Trinidad and …
Preliminary survey of extended-spectrum β-lactamases (ESBLs) in nosocomial uropathogen Klebsiella pneumoniae in north-central Iran
Infections caused by extended-spectrum β-lactamases (ESBLs) producing bacteria,
including Klebsiella pneumoniae have increasingly subjected to therapeutic limitations and …
including Klebsiella pneumoniae have increasingly subjected to therapeutic limitations and …
Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults
A Maharjan, A Bhetwal, S Shakya, D Satyal… - Infection and drug …, 2018 - Taylor & Francis
Background: Fecal carriage of multidrug-resistant and extended-spectrum β-lactamase
(ESBL)-producing Enterobacteriaceae is one of the important risk factors for infection with …
(ESBL)-producing Enterobacteriaceae is one of the important risk factors for infection with …
Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination …
Objectives To characterize extended-spectrum β-lactamase (ESBL)-producing Escherichia
coli isolates from the community, determine their antibiotic sensitivity profiles and quinolone …
coli isolates from the community, determine their antibiotic sensitivity profiles and quinolone …
Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: A prospective pilot study
E Demonchy, J Courjon, E Ughetto, M Durand… - International journal of …, 2018 - Elsevier
The emergence of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E)
infections requires re-assessment of therapeutic choices. Here we report the efficacy of …
infections requires re-assessment of therapeutic choices. Here we report the efficacy of …
How should we treat hospital-acquired and ventilator-associated pneumonia caused by extended-spectrum β-lactamase–producing Enterobacteriaceae?
Hospital-acquired and ventilator-associated pneumonia (HAP/VAP) due to extended-
spectrum β-lactamase–producing Enterobacteriaceae (ESBL-PE) represent a growing …
spectrum β-lactamase–producing Enterobacteriaceae (ESBL-PE) represent a growing …
[HTML][HTML] Clinical outcomes of carbapenem de-escalation regardless of microbiological results: a propensity score analysis
S Sadyrbaeva-Dolgova, P Aznarte-Padial… - International Journal of …, 2019 - Elsevier
Objective The aim of this study was to evaluate the safety and efficacy of de-escalation in
patients under treatment with carbapenems and its impact on clinical outcomes. Methods A …
patients under treatment with carbapenems and its impact on clinical outcomes. Methods A …